PF381 FACTORS IMPACTING TREATMENT SELECTION IN TREATMENT-NAÏVE PATIENTS WITH CLL: A MULTICENTER STUDY

Autor: George A. Follows, Brian T. Hill, Alan P Skarbnik, Barbara Eichhorst, Rajat Bannerji, Kaitlin Kennard, Allison M. Winter, M. Sarraf Yazdy, Kavita Sail, Toby A. Eyre, Stephen J. Schuster, Andrew M. Evens, John N. Allan, Chaitra S. Ujjani, Mazyar Shadman, D. Dingfeng Jiang, Anthony R. Mato, Lindsey E. Roeker, Anna Schuh, Chadi Nabhan, Hande H. Tuncer, William G. Wierda, James M. Pauff, Danielle M. Brander, Jennifer R. Brown, Christopher P. Fox, Paul M. Barr, Simon Sharmokh, Bruce D. Cheson, Nicole Lamanna, Joanna Rhodes, Sang Kyu Cho

Publikováno v: HemaSphere. 3:142

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a5337c2659238553e17143b98f75dd72
https://doi.org/10.1097/01.hs9.0000559736.57279.87

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell Lymphomas.

Autor: Sarraf Yazdy M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Kasamon YL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gu W; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Rodriguez LR; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Jin S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bhatnagar V; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Richardson NC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Theoret MR; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Gormley NJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Dec 16; Vol. 30 (24), pp. 5521-5526.